<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35830061</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2237-9622</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>2</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil</Title><ISOAbbreviation>Epidemiol Serv Saude</ISOAbbreviation></Journal><ArticleTitle>Supply/demand ratio for medical consultations, diagnostic tests and chronic kidney disease monitoring in the Brazilian National Health System: a descriptive study, state of S&#xe3;o Paulo, Brazil, 2019.</ArticleTitle><Pagination><StartPage>e20211050</StartPage><MedlinePgn>e20211050</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e20211050</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1590/S2237-96222022000200014</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2237-96222022000200307</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To determine the supply/demand ratio for procedures related to diagnosis and treatment for chronic kidney disease in the Brazilian National Health System (SUS), in the state of S&#xe3;o Paulo, Brazil, 2019.</AbstractText><AbstractText Label="METHODS">This was a descriptive study, using data from the SUS outpatient and hospital information systems. The numbers of medical consultations, diagnostic and chronic kidney disease monitoring tests, performed in the period, were compared with the demand estimation, obtained through ministerial guidelines.</AbstractText><AbstractText Label="RESULTS">Exclusive SUS users were 28,791,244, and individuals with arterial hypertension and/or diabetes mellitus, 5,176,188. The number of procedures performed and the ratio between this number and the needs of the population were 389,414 consultations with nephrologists (85%); 11,540,371 serum creatinine tests (223%); 705,709 proteinuria tests (14%); 438,123 kidney ultrasounds (190%); and 1,045 kidney biopsies (36%).</AbstractText><AbstractText Label="CONCLUSION">In the chronic kidney disease care in the SUS it could be seen simultaneous existence of lack of supply, waste and inadequate screening of important procedures.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Samaan</LastName><ForeName>Farid</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-4393-7330</Identifier><AffiliationInfo><Affiliation>Secretaria de Estado da Sa&#xfa;de de S&#xe3;o Paulo, Grupo de Planejamento e Avalia&#xe7;&#xe3;o, S&#xe3;o Paulo, SP, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gutierrez</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6465-5773</Identifier><AffiliationInfo><Affiliation>Secretaria de Estado da Sa&#xfa;de de S&#xe3;o Paulo, Grupo de Planejamento e Avalia&#xe7;&#xe3;o, S&#xe3;o Paulo, SP, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirsztajn</LastName><ForeName>Gianna Mastroianni</ForeName><Initials>GM</Initials><Identifier Source="ORCID">0000-0003-1317-4109</Identifier><AffiliationInfo><Affiliation>Universidade Federal de S&#xe3;o Paulo, Faculdade de Medicina, S&#xe3;o Paulo, SP, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sesso</LastName><ForeName>Ricardo Cintra</ForeName><Initials>RC</Initials><Identifier Source="ORCID">0000-0002-1062-0073</Identifier><AffiliationInfo><Affiliation>Universidade Federal de S&#xe3;o Paulo, Faculdade de Medicina, S&#xe3;o Paulo, SP, Brasil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>por</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Raz&#xe3;o oferta/necessidade de consultas m&#xe9;dicas, exames de diagn&#xf3;stico e acompanhamento da doen&#xe7;a renal cr&#xf4;nica no Sistema &#xda;nico de Sa&#xfa;de: estudo descritivo, estado de S&#xe3;o Paulo, 2019.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Epidemiol Serv Saude</MedlineTA><NlmUniqueID>101248287</NlmUniqueID><ISSNLinking>1679-4974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003955" MajorTopicYN="Y">Diagnostic Tests, Routine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012017" MajorTopicYN="N">Referral and Consultation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="Y">Renal Insufficiency, Chronic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="por"><AbstractText Label="OBJETIVO">Determinar a raz&#xe3;o oferta/necessidade de procedimentos relacionados com o diagn&#xf3;stico e assist&#xea;ncia &#xe0; doen&#xe7;a renal cr&#xf4;nica no Sistema &#xda;nico de Sa&#xfa;de (SUS), no estado de S&#xe3;o Paulo, Brasil, 2019.</AbstractText><AbstractText Label="M&#xc9;TODOS">Estudo descritivo, utilizando dados dos sistemas de informa&#xe7;&#xf5;es ambulatoriais e hospitalares do SUS. Os n&#xfa;meros de consultas m&#xe9;dicas e exames diagn&#xf3;sticos e de acompanhamento da doen&#xe7;a renal realizados no per&#xed;odo foram comparados com as estimativas de necessidade obtidas por diretrizes ministeriais.</AbstractText><AbstractText Label="RESULTADOS">Usu&#xe1;rios exclusivos do SUS eram 28.791.244, e indiv&#xed;duos com hipertens&#xe3;o e/ou diabetes mellitus, 5.176.188. O n&#xfa;mero de procedimentos realizados e a raz&#xe3;o entre esse n&#xfa;mero e a necessidade da popula&#xe7;&#xe3;o foram de 389.414 consultas com nefrologista (85%); 11.540.371 dosagens de creatinina s&#xe9;rica (223%); 705.709 dosagens de protein&#xfa;ria (14%); 438.123 ultrassonografias renais (190%); e 1.045 bi&#xf3;psias renais (36%).</AbstractText><AbstractText Label="CONCLUS&#xc3;O">Na assist&#xea;ncia &#xe0; doen&#xe7;a renal cr&#xf4;nica no SUS existem, simultaneamente, falta de oferta, desperd&#xed;cio e rastreamento deficiente de procedimentos importantes.</AbstractText></OtherAbstract><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="OBJETIVO">Determinar la relaci&#xf3;n oferta/necesidad de procedimientos relacionados con el diagn&#xf3;stico y atenci&#xf3;n de la enfermedad renal cr&#xf3;nica en Sistema &#xda;nico de Salud (SUS) del Estado de S&#xe3;o Paulo, Brasil, en 2019.</AbstractText><AbstractText Label="M&#xc9;TODOS">Estudio descriptivo utilizando datos de los sistemas de informaci&#xf3;n ambulatoria y hospitalaria del SUS. Se compar&#xf3; el n&#xfa;mero de consultas m&#xe9;dicas, pruebas de diagn&#xf3;stico y seguimiento de la enfermedad renal realizados con las estimaciones de necesidad recomendadas por directrices ministeriales.</AbstractText><AbstractText Label="RESULTADOS">Los usuarios exclusivos de SUS fueron 28.791.244 e hipertensos y/o diab&#xe9;ticos, 5.176.188. El n&#xfa;mero de procedimientos realizados y la relaci&#xf3;n entre este n&#xfa;mero y la necesidad de la poblaci&#xf3;n fueran de 389.414 consultas con nefr&#xf3;logo (85%); 11.540.371 determinaciones de creatinina s&#xe9;rica (223%); 705.709 determinaciones de proteinuria (14%); 438.123 ecograf&#xed;as renales (190%); y 1.045 biopsias renales (36%).</AbstractText><AbstractText Label="CONCLUSI&#xd3;N">En la atenci&#xf3;n de enfermedad renal en SUS existe, simult&#xe1;neamente, falta de oferta, desperdicio y seguimiento deficiente de procedimientos importantes.</AbstractText></OtherAbstract><CoiStatement><b>CONFLICTS OF INTEREST:</b> The authors declared that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>13</Day><Hour>11</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35830061</ArticleId><ArticleId IdType="pmc">PMC9887954</ArticleId><ArticleId IdType="doi">10.1590/S2237-96222022000200014</ArticleId><ArticleId IdType="pii">S2237-96222022000200307</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Luyckx VA, Tonelli M, Stanifer JW. The global burden of kidney disease and the sustainable development goals. Bull World Health Organ. 2018;96(6):414&#x2013;422D. doi: 10.2471/BLT.17.206441.</Citation><ArticleIdList><ArticleId IdType="doi">10.2471/BLT.17.206441</ArticleId><ArticleId IdType="pmc">PMC5996218</ArticleId><ArticleId IdType="pubmed">29904224</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens PE, Levin A. Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825&#x2013;830. doi: 10.7326/0003-4819-158-11-201306040-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-158-11-201306040-00007</ArticleId><ArticleId IdType="pubmed">23732715</ArticleId></ArticleIdList></Reference><Reference><Citation>Minist&#xe9;rio da Sa&#xfa;de (BR). Secretaria de Aten&#xe7;&#xe3;o &#xe0; Sa&#xfa;de.
Departamento de Aten&#xe7;&#xe3;o Especializada e Tem&#xe1;tica  . Diretrizes cl&#xed;nicas para o cuidado ao paciente com doen&#xe7;a renal cr&#xf4;nica
- DRC no Sistema &#xda;nico de Sa&#xfa;de [Internet] Bras&#xed;lia: Minist&#xe9;rio da Sa&#xfa;de; Bras&#xed;lia: Minist&#xe9;rio da Sa&#xfa;de; 2014.  [2021/02/13].  Dispon&#xed;vel em:  https://portalarquivos2.saude.gov.br/images/pdf/2014/marco/24/diretriz-cl--nica-drc-versao-final.pdf

.</Citation></Reference><Reference><Citation>Ene-Iordache B, Perico N, Bikbov B, Carminati S, Remuzzi A, Perna A, et al. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. Lancet Glob Health. 2016;4(5):e307&#x2013;e319. doi: 10.1016/S2214-109X(16)00071-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(16)00071-1</ArticleId><ArticleId IdType="pubmed">27102194</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendelssohn DC, Malmberg C, Hamandi B. An integrated review of "unplanned" dialysis initiation: reframing the terminology to "suboptimal" initiation. BMC Nephrol. 2009;10:22&#x2013;22. doi: 10.1186/1471-2369-10-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2369-10-22</ArticleId><ArticleId IdType="pmc">PMC2735745</ArticleId><ArticleId IdType="pubmed">19674452</ArticleId></ArticleIdList></Reference><Reference><Citation>Minist&#xe9;rio da Sa&#xfa;de (BR). Secretaria de Aten&#xe7;&#xe3;o &#xe0; Sa&#xfa;de.
Departamento de Regula&#xe7;&#xe3;o, Avalia&#xe7;&#xe3;o e Controle  . Crit&#xe9;rios e par&#xe2;metros assistenciais para o planejamento e programa&#xe7;&#xe3;o
de a&#xe7;&#xf5;es e servi&#xe7;os de sa&#xfa;de no &#xe2;mbito do Sistema &#xda;nico de Sa&#xfa;de
[Internet] Bras&#xed;lia: Minist&#xe9;rio da Sa&#xfa;de; 2017.  [2021/03/05].  Dispon&#xed;vel em:  https://bit.ly/3xBIrxq
.</Citation></Reference><Reference><Citation>Minist&#xe9;rio da Sa&#xfa;de (BR)   DATASUS - Tabnet: informa&#xe7;&#xf5;es de Sa&#xfa;de [Internet] Bras&#xed;lia: Minist&#xe9;rio da Sa&#xfa;de; 2020.  [2021/01/05].  Dispon&#xed;vel em:
https://datasus.saude.gov.br/informacoes-de-saude-tabnet/ 7Minist&#xe9;rio da
Sa&#xfa;deDATASUS - Tabnet: informa&#xe7;&#xf5;es de Sa&#xfa;de2020Bras&#xed;lia Minist&#xe9;rio da Sa&#xfa;de
[citado 2021/01/05]. Dispon&#xed;vel em:  https://datasus.saude.gov.br/informacoes-de-saude-tabnet 
.</Citation></Reference><Reference><Citation>Secretaria de Estado da Sa&#xfa;de (SP)   Matriz de indicadores de sa&#xfa;de [Internet] S&#xe3;o Paulo: Secretaria de Estado da Sa&#xfa;de; 2020.  [2021/02/10].  Dispon&#xed;vel em:  https://www.saude.sp.gov.br/links/matriz
.</Citation></Reference><Reference><Citation>Minist&#xe9;rio da Sa&#xfa;de (BR)   Cadastro Nacional de Estabelecimentos de Sa&#xfa;de: m&#xf3;dulo profissionais
[Internet] Bras&#xed;lia: Minist&#xe9;rio da Sa&#xfa;de; 2020.  [2021/03/20].  Dispon&#xed;vel em:  https://cnes.datasus.gov.br
.</Citation></Reference><Reference><Citation>Funda&#xe7;&#xe3;o Sistema Estadual de Dados  . Sistema SEADE de Proje&#xe7;&#xf5;es Populacionais [Internet] S&#xe3;o Paulo: Funda&#xe7;&#xe3;o Sistema Estadual de Dados; 2019.  [2021/04/05].  Dispon&#xed;vel em:  http://produtos.seade.gov.br/produtos/projpop
.</Citation></Reference><Reference><Citation>Minist&#xe9;rio da Sa&#xfa;de (BR). Secretaria de Vigil&#xe2;ncia em Sa&#xfa;de.
Departamento de An&#xe1;lise em Sa&#xfa;de e Vigil&#xe2;ncia de Doen&#xe7;as N&#xe3;o
Transmiss&#xed;veis  . Vigitel Brasil 2019: vigil&#xe2;ncia de fatores de risco e prote&#xe7;&#xe3;o para
doen&#xe7;as cr&#xf4;nicas por inqu&#xe9;rito telef&#xf4;nico: estimativas sobre frequ&#xea;ncia e
distribui&#xe7;&#xe3;o sociodemogr&#xe1;fica de fatores de risco e prote&#xe7;&#xe3;o para doen&#xe7;as
cr&#xf4;nicas nas capitais dos 26 estados brasileiros e no Distrito Federal em
2019 [Internet] Bras&#xed;lia: Minist&#xe9;rio da Sa&#xfa;de; 2020.  [2021/01/05].  Dispon&#xed;vel em:  https://bvsms.saude.gov.br/bvs/publicacoes/vigitel_brasil_2019_vigilancia_fatores_risco.pdf
.</Citation></Reference><Reference><Citation>Freitas LRS, Garcia LP. Evolu&#xe7;&#xe3;o da preval&#xea;ncia do diabetes e deste associado &#xe0; hipertens&#xe3;o arterial no Brasil: an&#xe1;lise da Pesquisa Nacional por Amostra de Domic&#xed;lios, 1998, 2003 e 2008. Epidemiol Serv Saude. 2012;21(1):7&#x2013;19. doi: 10.5123/S1679-49742012000100002.</Citation><ArticleIdList><ArticleId IdType="doi">10.5123/S1679-49742012000100002</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorentino M, Bolignano D, Tesar V, Pisano A, Van Biesen W, D&amp;apos;Arrigo G, et al. Renal biopsy in 2015-from epidemiology to evidence-based indications. Am J Nephrol. 2016;43(1):1&#x2013;19. doi: 10.1159/000444026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000444026</ArticleId><ArticleId IdType="pubmed">26844777</ArticleId></ArticleIdList></Reference><Reference><Citation>Ag&#xea;ncia Nacional de Sa&#xfa;de Suplementar  . ANS Tabnet - Informa&#xe7;&#xf5;es em sa&#xfa;de complementar: taxa de cobertura de
planos de sa&#xfa;de [Internet] Bras&#xed;lia: Ag&#xea;ncia Nacional de Sa&#xfa;de Suplementar; 2012.  [2021/01/15].  Dispon&#xed;vel em:  http://www.ans.gov.br/anstabnet/cgi-bin/dh?dados/tabnet_tx.def
.</Citation></Reference><Reference><Citation>Vejakama P, Ingsathit A, McKay GJ, Maxwell AP, McEvoy M, Attia J, et al. Treatment effects of renin-angiotensin aldosterone system blockade on kidney failure and mortality in chronic kidney disease patients. BMC Nephrology. 2017;18(1):342&#x2013;342. doi: 10.1186/s12882-017-0753-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-017-0753-9</ArticleId><ArticleId IdType="pmc">PMC5706339</ArticleId><ArticleId IdType="pubmed">29187194</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoungas S, Arima H, Gerstein HC, Holman RR, Woodward M, Reaven P, et al. Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomized controlled trials. Lancet Diabetes Endocrinol. 2017;5(6):431&#x2013;443. doi: 10.1016/S2213-8587(17)30104-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(17)30104-3</ArticleId><ArticleId IdType="pubmed">28365411</ArticleId></ArticleIdList></Reference><Reference><Citation>Doty MM, Tikkanen R, Shah A, Schneider EC. Primary care physicians&amp;apos; role in coordinating medical and health-related social needs in eleven countries. Health Aff (Millwood) 2020;39(1):115&#x2013;123. doi: 10.1377/hlthaff.2019.01088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2019.01088</ArticleId><ArticleId IdType="pubmed">31821045</ArticleId></ArticleIdList></Reference><Reference><Citation>Arena TR, Jeric&#xf3; MC, Castro LC, Castilho V, Lima AF. Gastos com exames complementares desnecess&#xe1;rios para hipertensos e diab&#xe9;ticos nos servi&#xe7;os de sa&#xfa;de. Rev Gaucha Enferm. 2014;35(4):86&#x2013;93. doi: 10.1590/1983-1447.2014.04.44793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1983-1447.2014.04.44793</ArticleId><ArticleId IdType="pubmed">25842785</ArticleId></ArticleIdList></Reference><Reference><Citation>Arieta CEL, Nascimento MA, Lira RPC, Kara-Jos&#xe9; N. Desperd&#xed;cio de exames complementares na avalia&#xe7;&#xe3;o pr&#xe9;-operat&#xf3;ria em cirurgias de catarata. Cad Saude Publica. 2004;20(1):303&#x2013;310. doi: 10.1590/S0102-311X2004000100048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0102-311X2004000100048</ArticleId><ArticleId IdType="pubmed">15029333</ArticleId></ArticleIdList></Reference><Reference><Citation>Carregaro RL, Silva EN, van Tulder M. Direct healthcare costs of spinal disorders in Brazil. Int J Public Health. 2019;64(6):965&#x2013;974. doi: 10.1007/s00038-019-01211-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00038-019-01211-6</ArticleId><ArticleId IdType="pubmed">31093690</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebel G, S&#xe1; AR, Junior, Campos EMS, Loures FB, Dias PV, Chaoubah A. O diagn&#xf3;stico por imagem no Brasil: um sistema, muitas realidades. J Bras Econ Saude. 2018;10(3):291&#x2013;297. doi: 10.21115/JBES.v10.n3.p291-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.21115/JBES.v10.n3.p291-7</ArticleId></ArticleIdList></Reference><Reference><Citation>NHS England Analytical Services (Operations)   NHS Imaging and Radiodiagnostic activity: 2013/14 Release
[Internet] Redditch: NHS England; 2014.  [2021/08/10].  Available from:  https://www.england.nhs.uk/statistics/wp-content/uploads/sites/2/2013/04/KH12-release-2013-14.pdf
.</Citation></Reference><Reference><Citation>United States Renal Data System  . Chapter 2: Identification and care of patients with chronic kidney
disease. Bethesda: United States Renal Data System; 2017.  [2021/09/15].   Avaliable from:  https://www.usrds.org/media/1510/v1_ch_02_care-and-id-of-ckd-patients.pdf
.</Citation></Reference><Reference><Citation>Plantinga LC, Tuot DS, Powe NR. Awareness of chronic kidney disease among patients and providers. Adv Chronic Kidney Dis. 2010;17(3):225&#x2013;236. doi: 10.1053/j.ackd.2010.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ackd.2010.03.002</ArticleId><ArticleId IdType="pmc">PMC2864779</ArticleId><ArticleId IdType="pubmed">20439091</ArticleId></ArticleIdList></Reference><Reference><Citation>Organiza&#xe7;&#xe3;o Pan-Americana da Sa&#xfa;de  . Linhas de cuidado: hipertens&#xe3;o arterial e diabetes [Internet] Bras&#xed;lia: Organiza&#xe7;&#xe3;o Pan-Americana da Sa&#xfa;de; 2010.  [2021/06/08].  Dispon&#xed;vel em:  https://bvsms.saude.gov.br/bvs/publicacoes/linhas_cuidado_hipertensao_diabetes.pdf
.</Citation></Reference><Reference><Citation>Shao S, Zhang H, Chen X, Xu X, Zhao Y, Wang M, et al. Health education services utilization and its determinants among migrants: a cross-sectional study in urban-rural fringe areas of Beijing, China. BMC Fam Pract. 2021;22(1):23&#x2013;23. doi: 10.1186/s12875-021-01368-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12875-021-01368-1</ArticleId><ArticleId IdType="pmc">PMC7811350</ArticleId><ArticleId IdType="pubmed">33453725</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheffer M.  Demografia m&#xe9;dica no Brasil: 2018 [Internet] S&#xe3;o Paulo: CREMESP; 2018.  [2021/09/19].  Dispon&#xed;vel em:  http://www.epsjv.fiocruz.br/sites/default/files/files/DemografiaMedica2018%20(3).pdf
.</Citation></Reference><Reference><Citation>Field M. Addressing the global shortage of nephrologists. Nat Clin Pract Nephrol. 2008;4(11):583&#x2013;583. doi: 10.1038/ncpneph0951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncpneph0951</ArticleId><ArticleId IdType="pubmed">18956002</ArticleId></ArticleIdList></Reference><Reference><Citation>Luciano RL, Moeckel GW. Update on the native kidney biopsy: core curriculum 2019. Am J Kidney Dis. 2019;73(3):404&#x2013;415. doi: 10.1053/j.ajkd.2018.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2018.10.011</ArticleId><ArticleId IdType="pubmed">30661724</ArticleId></ArticleIdList></Reference><Reference><Citation>Thom&#xe9; FS, Sesso RC, Lopes AA, Lugon JR, Martins CT. Brazilian chronic dialysis survey 2017. Braz J Nephrol. 2019;41(2):208&#x2013;214. doi: 10.1590/2175-8239-JBN-2018-0178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/2175-8239-JBN-2018-0178</ArticleId><ArticleId IdType="pmc">PMC6699436</ArticleId><ArticleId IdType="pubmed">30968930</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32166922</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2445-2807</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month><Day>20</Day></PubDate></JournalIssue><Title>Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica</Title><ISOAbbreviation>Cir Pediatr</ISOAbbreviation></Journal><ArticleTitle>Serial voiding urosonography in posterior urethral valve diagnosis and management in pediatric patients.</ArticleTitle><Pagination><StartPage>36</StartPage><EndPage>42</EndPage><MedlinePgn>36-42</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Report our experience with the use of contrast-enhanced serial voiding urosonography (SVU) for posterior urethral valve (PUV) patient diagnosis and management.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Descriptive retrospective study in 0- to 14-year-old patients with suspected PUV at SVU performed as a first contrast-enhanced urinary tract test with subsequent cystoscopic study. Variables were analyzed using SPSSv22.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">18 patients were studied (median age: 6 months). Most patients (15) presented posterior urethral dilatation (mean diameter: 9.56&#xa0;mm) and a &gt;2&#xa0;mm gap between proximal and distal urethra. 13 cases had bladder thickening and 9 had VUR. 15 PUV cases, 1 case of distal urethral mucocele, and 1 case of bladder diverticulum obstructing the urethra were diagnosed. Complete PUV resection was performed in 10 patients (66.6%) at the first cystoscopy. The control SVU detected one case of recurrence due to persistence of posterior urethral dilatation. The recurrence case and the 5 incomplete resection cases were treated with a second cystoscopy and resection. The youngest patients required a third resection and cutting balloon dilatation due to residual stenosis. Mean creatinine levels at diagnosis were 0.28&#xa0;mg/dl.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Serial voiding urosonography (SVU) is a useful complementary test in pediatric patients with posterior urethral valve. Its dynamic nature and its advantages -&#xa0;absence of irradiation, safety, and high sensitivity&#xa0;- make it an ideal imaging test for PUV diagnosis and follow-up.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rojas-Ticona</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Pediatric Surgery Department. Complejo Hospitalario Universitario de Albacete. Albacete (Spain).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez C&#xf3;rdoba</LastName><ForeName>M S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Pediatric Surgery Department. Complejo Hospitalario Universitario de Albacete. Albacete (Spain).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabezal&#xed; Barbancho</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Pediatric Surgery Department, Pediatric Urology Unit. Hospital Universitario 12 de Octubre. Madrid (Spain).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mariju&#xe1;n Sahuquillo</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Pediatric Surgery Department. Complejo Hospitalario Universitario de Albacete. Albacete (Spain).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Argumosa Salazar</LastName><ForeName>Y M</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Pediatric Surgery Department. Complejo Hospitalario Universitario de Albacete. Albacete (Spain).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ram&#xed;rez Piqueras</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pediatric Surgery Department. Complejo Hospitalario Universitario de Albacete. Albacete (Spain).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moratalla Jare&#xf1;o</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Pediatric Surgery Department. Complejo Hospitalario Universitario de Albacete. Albacete (Spain).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez Anselmi</LastName><ForeName>E J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Pediatric Surgery Department. Complejo Hospitalario Universitario de Albacete. Albacete (Spain).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vidal Company</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pediatric Department's, Pediatric Nephrology Unit. Complejo Hospitalario Universitario de Albacete. Albacete (Spain).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parrondo Mui&#xf1;os</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Radiologic Department's. Complejo Hospitalario Universitario de Albacete. Albacete (Spain).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Urosonograf&#xed;a miccional seriada en el diagn&#xf3;stico y manejo de las v&#xe1;lvulas de uretra posterior en pacientes pedi&#xe1;tricos.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Cir Pediatr</MedlineTA><NlmUniqueID>8900492</NlmUniqueID><ISSNLinking>0214-1221</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003287" MajorTopicYN="N">Contrast Media</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003558" MajorTopicYN="Y">Cystoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="N">Reoperation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014463" MajorTopicYN="N">Ultrasonography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014521" MajorTopicYN="N">Urethra</DescriptorName><QualifierName UI="Q000002" MajorTopicYN="Y">abnormalities</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014522" MajorTopicYN="N">Urethral Diseases</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014554" MajorTopicYN="N">Urination</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="OBJETIVOS" NlmCategory="OBJECTIVE">Comunicar nuestra experiencia con la utilizaci&#xf3;n de la urosonograf&#xed;a miccional seriada (UMS) para el diagn&#xf3;stico y manejo de pacientes con v&#xe1;lvulas de uretra posterior (VUP).</AbstractText><AbstractText Label="MATERIAL Y METODOS" NlmCategory="METHODS">Estudio retrospectivo descriptivo en pacientes entre 0 a 14 a&#xf1;os con sospecha de VUP en UMS realizada como primera prueba contrastada de la v&#xed;a urinaria y con estudio cistosc&#xf3;pico posterior. Las variables se analizaron utilizando SPSSv22.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="RESULTS">Fueron estudiados 18 pacientes (edad mediana de 6 meses). La mayor&#xed;a de los pacientes (15) presentaban dilataci&#xf3;n de la uretra posterior (di&#xe1;metro medio de 9,56 mm) y diferencia entre uretra proximal y distal mayor de 2 mm. Trece casos ten&#xed;an engrosamiento vesical y 9 RVU. Se diagnosticaron 15 casos de VUP, 1 caso de mucocele de uretra distal y 1 divert&#xed;culo vesical que obstru&#xed;a uretra. Se consigui&#xf3; resecci&#xf3;n completa de las VUP en 10 pacientes (66,6%) en la primera cistoscopia. La UMS de control detect&#xf3; un caso de resecci&#xf3;n incompleta por persistencia de dilataci&#xf3;n de uretra posterior. Este caso y los 5 conocidos con resecci&#xf3;n incompleta se sometieron a una segunda cistoscopia y resecci&#xf3;n. El menor de los pacientes requiri&#xf3; una tercera resecci&#xf3;n y dilataci&#xf3;n con bal&#xf3;n de corte por estenosis residual. La creatinina media al diagn&#xf3;stico fue 0,28 mg/dl.</AbstractText><AbstractText Label="CONCLUSIONES" NlmCategory="CONCLUSIONS">La urosonograf&#xed;a miccional seriada (UMS) es una prueba complementaria &#xfa;til en pacientes pedi&#xe1;tricos con v&#xe1;lvulas de uretra posterior. Su car&#xe1;cter din&#xe1;mico y ventajas: ausencia de irradiaci&#xf3;n, seguridad y alta sensibilidad; la convierten en una prueba de imagen ideal para el diagn&#xf3;stico y seguimiento de VUP.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Posterior urethral valves</Keyword><Keyword MajorTopicYN="N">Ultrasound cystography</Keyword><Keyword MajorTopicYN="N">Voiding urosonography</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32166922</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27904153</PMID><DateCompleted><Year>2017</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1435-232X</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of human genetics</Title><ISOAbbreviation>J Hum Genet</ISOAbbreviation></Journal><ArticleTitle>Genotype and phenotype characterization in a Spanish cohort with isovaleric acidemia.</ArticleTitle><Pagination><StartPage>355</StartPage><EndPage>360</EndPage><MedlinePgn>355-360</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/jhg.2016.144</ELocationID><Abstract><AbstractText>Isovaleric acidemia (IVA) is a rare disorder of leucine metabolism. We carried out a multicenter study of IVA patients diagnosed by newborn screening (NBS) or symptoms clinics over a period of 28 years in Spain. Evaluated at diagnosis, data included age, detection method, levels of C5 and IVG, enzymatic studies, clinical presentation parameters and genotype in 16 patients. Follow-up data included C5 levels, intellectual quotient and correlation genotype-phenotype. IVA was detected by NBS in 8 patients (prevalence of 1/326&#x2009;629). Except 1, all the 8 patients identified by NBS were asymptomatic at diagnosis and had isovalerylcarnitine (C5) levels of 1.6-6.4&#x2009;&#x3bc;M and isovalerylglycine (IVG) levels &lt;1100&#x2009;mmol per mol creatinine; they remained asymptomatic with a natural protein intake &#x2a7e;1.5&#x2009;g&#x2009;kg<sup>-1</sup>&#x2009;per&#x2009;day. Symptomatic patients with chronic intermittent or acute neonatal IVA had C5 levels of 3.9-16.3&#x2009;&#x3bc;M and IVG levels &gt;3400&#x2009;mmol per mol creatinine. The percentage of isovalerate incorporation in fibroblasts was 64-80% in patients detected by NBS and 4.9-13% in symptomatic patients. Cognitive function was within normal ranges in all patients but was negatively correlated with IVG at detection (-0.592; P&lt;0.05). The genetic analysis revealed nine novel mutations. The clinical/biochemical phenotype correlated fairly well with the phenotype predicted by the mutations found. In conclusion, although blood C5 levels have traditionally been considered the prognostic marker of choice, urine IVG levels would appear to be a better predictor, as they correlated well with severity of mutations and were associated with a lower incorporation rate of IVA in fibroblasts and a less favorable clinical course.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Couce</LastName><ForeName>Mar&#xed;a L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Unit of Diagnosis and Treatment of Congenital Metabolic Diseases, Service of Neonatology, Department of Pediatrics, Hospital Cl&#xed;nico Universitario de Santiago, Health Research Institute of Santiago de Compostela (IDIS), CIBERER, Santiago de Compostela, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aldamiz-Echevarr&#xed;a</LastName><ForeName>Lu&#xed;s</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Unit of Metabolism, Department of Pediatrics, Hospital de Cruces, Group of Metabolism, Biocruces Health Research Institute, Barakaldo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bueno</LastName><ForeName>Mar&#xed;a A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Metabolic Disorders, Dietetics and Nutrition Unit, Virgen del Roc&#xed;o University Hospital, Sevilla, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barros</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Pediatric Gastroenterology, Hospital San Pedro de Alcantara, C&#xe1;ceres, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belanger-Quintana</LastName><ForeName>Amaya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Nutrition and Metabolic Unit, Service of Pediatrics, Hospital Universitario Ram&#xf3;n y Cajal, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blasco</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Gastroenterology, Hepatology and Child Nutrition Unit, Carlos Haya University Hospital, M&#xe1;laga, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Silva</LastName><ForeName>Mar&#xed;a-Teresa</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Unidad de Enfermedades Mitocondriales-Enfermedades Metab&#xf3;licas Hereditarias, Hospital 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xe1;rquez-Armenteros</LastName><ForeName>Ana M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Unit of Pediatric Gastroenterology and Metabolic Diseases, Hospital Materno Infantil de Badajoz, Badajoz, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vitoria</LastName><ForeName>Isidro</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Unit of Metabolopathies, Hospital Universitario la Fe, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vives</LastName><ForeName>Inmaculada</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Gastroenterology Unit, Pediatric Service, Virgen de la Arrixaca University Hospital, Murcia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navarrete</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centro de Diagn&#xf3;stico de Enfermedades Moleculares, Universidad Aut&#xf3;noma de Madrid, IdiPaz, CIBERER, ICIII, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Marmiesse</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unit of Diagnosis and Treatment of Congenital Metabolic Diseases, Service of Neonatology, Department of Pediatrics, Hospital Cl&#xed;nico Universitario de Santiago, Health Research Institute of Santiago de Compostela (IDIS), CIBERER, Santiago de Compostela, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;rez</LastName><ForeName>Bel&#xe9;n</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Centro de Diagn&#xf3;stico de Enfermedades Moleculares, Universidad Aut&#xf3;noma de Madrid, IdiPaz, CIBERER, ICIII, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;rez-Cerd&#xe1;</LastName><ForeName>Celia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centro de Diagn&#xf3;stico de Enfermedades Moleculares, Universidad Aut&#xf3;noma de Madrid, IdiPaz, CIBERER, ICIII, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>12</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Hum Genet</MedlineTA><NlmUniqueID>9808008</NlmUniqueID><ISSNLinking>1434-5161</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D045782">Hemiterpenes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010421">Pentanoic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>1BR7X184L5</RegistryNumber><NameOfSubstance UI="C008216">isovaleric acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>23590-18-3</RegistryNumber><NameOfSubstance UI="C005916">N-isovalerylglycine</NameOfSubstance></Chemical><Chemical><RegistryNumber>31023-24-2</RegistryNumber><NameOfSubstance UI="C027333">3-methylbutyrylcarnitine</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.3.8.4</RegistryNumber><NameOfSubstance UI="D050769">Isovaleryl-CoA Dehydrogenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>S7UI8SM58A</RegistryNumber><NameOfSubstance UI="D002331">Carnitine</NameOfSubstance></Chemical><Chemical><RegistryNumber>TE7660XO1C</RegistryNumber><NameOfSubstance UI="D005998">Glycine</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C538167">Acidemia, isovaleric</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000592" MajorTopicYN="N">Amino Acid Metabolism, Inborn Errors</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058070" MajorTopicYN="N">Asymptomatic Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002331" MajorTopicYN="N">Carnitine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="Y">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005998" MajorTopicYN="N">Glycine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045782" MajorTopicYN="N">Hemiterpenes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050769" MajorTopicYN="N">Isovaleryl-CoA Dehydrogenase</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="Y">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015997" MajorTopicYN="N">Neonatal Screening</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010421" MajorTopicYN="N">Pentanoic Acids</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27904153</ArticleId><ArticleId IdType="doi">10.1038/jhg.2016.144</ArticleId><ArticleId IdType="pii">jhg2016144</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Am J Hum Genet. 2000 Feb;66(2):356-67</Citation><ArticleIdList><ArticleId IdType="pubmed">10677295</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapid Commun Mass Spectrom. 2012 Sep 30;26(18):2131-44</Citation><ArticleIdList><ArticleId IdType="pubmed">22886809</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 2006 May;117(5 Pt 2):S261-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16735252</ArticleId></ArticleIdList></Reference><Reference><Citation>J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Dec 1;860(1):121-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17988960</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Genet Metab. 2007 Feb;90(2):134-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17027310</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Chem. 2011 Apr;57(4):623-6</Citation><ArticleIdList><ArticleId IdType="pubmed">21335445</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 Jun 5;348(23):2304-12</Citation><ArticleIdList><ArticleId IdType="pubmed">12788994</ArticleId></ArticleIdList></Reference><Reference><Citation>Prenat Diagn. 1995 Jun;15(6):527-33</Citation><ArticleIdList><ArticleId IdType="pubmed">7659686</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 2003 Jun;111(6 Pt 1):1399-406</Citation><ArticleIdList><ArticleId IdType="pubmed">12777559</ArticleId></ArticleIdList></Reference><Reference><Citation>Genomics. 1993 Mar;15(3):582-90</Citation><ArticleIdList><ArticleId IdType="pubmed">8468053</ArticleId></ArticleIdList></Reference><Reference><Citation>J Inherit Metab Dis. 2014 Nov;37(6):889-98</Citation><ArticleIdList><ArticleId IdType="pubmed">25022222</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Int. 2011 Dec;53(6):990-4</Citation><ArticleIdList><ArticleId IdType="pubmed">22004070</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Med Genet. 2012 Dec;55(12):671-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22960500</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet C Semin Med Genet. 2006 May 15;142C(2):95-103</Citation><ArticleIdList><ArticleId IdType="pubmed">16602101</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Med Genet. 2014 Oct;57(10):596-601</Citation><ArticleIdList><ArticleId IdType="pubmed">25220015</ArticleId></ArticleIdList></Reference><Reference><Citation>Korean J Pediatr. 2013 Aug;56(8):351-4</Citation><ArticleIdList><ArticleId IdType="pubmed">24019846</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr. 1978 May;92(5):813-7</Citation><ArticleIdList><ArticleId IdType="pubmed">641635</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochemistry. 1998 Jul 14;37(28):10325-35</Citation><ArticleIdList><ArticleId IdType="pubmed">9665741</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Pediatr. 1979 Jun 28;131(3):205-11</Citation><ArticleIdList><ArticleId IdType="pubmed">477679</ArticleId></ArticleIdList></Reference><Reference><Citation>J Inherit Metab Dis. 2012 Nov;35(6):1021-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22350545</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 1991 Jul;49(1):147-57</Citation><ArticleIdList><ArticleId IdType="pubmed">2063866</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Genet Metab. 2007 Sep-Oct;92(1-2):71-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17576084</ArticleId></ArticleIdList></Reference><Reference><Citation>Tohoku J Exp Med. 2015 ;236(2):103-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26018748</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2004 Dec;75(6):1136-42</Citation><ArticleIdList><ArticleId IdType="pubmed">15486829</ArticleId></ArticleIdList></Reference><Reference><Citation>Free Radic Res. 2008 Aug;42(8):707-15</Citation><ArticleIdList><ArticleId IdType="pubmed">18661426</ArticleId></ArticleIdList></Reference><Reference><Citation>J Inherit Metab Dis. 2015 Nov;38(6):1059-74</Citation><ArticleIdList><ArticleId IdType="pubmed">25875216</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1966 Jul;56(1):236-42</Citation><ArticleIdList><ArticleId IdType="pubmed">5229850</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 1984 Dec;74(6):2290-5</Citation><ArticleIdList><ArticleId IdType="pubmed">6549017</ArticleId></ArticleIdList></Reference><Reference><Citation>Orphanet J Rare Dis. 2012 Jan 25;7:9</Citation><ArticleIdList><ArticleId IdType="pubmed">22277694</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">20815152</PMID><DateCompleted><Year>2010</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2010</Year><Month>09</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0535-5133</ISSN><JournalIssue CitedMedium="Print"><Volume>51</Volume><Issue>1</Issue><PubDate><Year>2010</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Investigacion clinica</Title><ISOAbbreviation>Invest Clin</ISOAbbreviation></Journal><ArticleTitle>[Distal renal tubular dysfunction in seriously undernourished pediatric patients].</ArticleTitle><Pagination><StartPage>5</StartPage><EndPage>16</EndPage><MedlinePgn>5-16</MedlinePgn></Pagination><Abstract><AbstractText>Seriously undernourished patients have a bigger tendency to metabolic acidosis than euthrophic individuals. The objective of the present work was to realize a study of the renal tubular function in 30 severely undernourished children. The investigation was a prospective, descriptive and transversal study. A test of overload with 5% sodium bicarbonate was realized to 30 seriously undernourished children whose primari etiology was marasmus, kwashiorkor or with mixed conditions, with ages of 6 months to 5 years, from both sexes, hemodynamically stable, with metabolic acidosis, hiperchloremia and positive urinary anion gap. The relation calcium/creatinine and the index uric acid/creatinine were determined. The absolute and relatives frequencies, average values and standard deviations were calculated. Infants represented 80% of the evaluated patients. The clinical forms kwashiorkor and mixed forms, of chronic evolution prevailed. Distal tubular renal acidosis was observed in 12 patients (40%) after the test overload with 5% bicarbonate. The average values of the relation calcium/creatinine of children &lt;2 years was 0.362 +/- 0.414 and of children &gt;2 years was 0.265 +/- 0.222. The uric acid/creatinine index was 0.57 +/- 0.28. Metabolic acidosis is frequent in serious infantile undernourishment, which, according to the results observed, obeys to distal renal tubular dysfunction. The interpretation of the relation calcium/creatinine and the uric acid/creatinine index is difficult, becoming necessary to increase the investigations in these patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barbella-Szarvas</LastName><ForeName>Sobeida</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Unidad de Investigaci&#xf3;n en Gastroenterolog&#xed;a y Nutrici&#xf3;n Pedi&#xe1;trica, Universidad de Carabobo, Valencia, Venezuela. sobeida2001@yahoo.fr</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dom&#xed;nguez</LastName><ForeName>Luis</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Castro-Kolster</LastName><ForeName>Cruz</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Callegari</LastName><ForeName>Carlos</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Marcano</LastName><ForeName>Grace</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Villanueva</LastName><ForeName>Crisley</ForeName><Initials>C</Initials></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><VernacularTitle>Disfunci&#xf3;n tubular renal distal en pacientes pedi&#xe1;tricos con diagn&#xf3;stico de desnutrici&#xf3;n grave.</VernacularTitle></Article><MedlineJournalInfo><Country>Venezuela</Country><MedlineTA>Invest Clin</MedlineTA><NlmUniqueID>0421531</NlmUniqueID><ISSNLinking>0535-5133</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000138" MajorTopicYN="N">Acidosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007686" MajorTopicYN="N">Kidney Tubules, Distal</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044342" MajorTopicYN="N">Malnutrition</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20815152</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">18590497</PMID><DateCompleted><Year>2008</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2009</Year><Month>01</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0211-6995</ISSN><JournalIssue CitedMedium="Print"><Volume>28</Volume><Issue>3</Issue><PubDate><Year>2008</Year></PubDate></JournalIssue><Title>Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia</Title><ISOAbbreviation>Nefrologia</ISOAbbreviation></Journal><ArticleTitle>[Comparison and agreement of the Cockcroft-Gault and MDRD equations to estimate glomerular filtration rate in diagnosis of occult chronic kidney disease].</ArticleTitle><Pagination><StartPage>301</StartPage><EndPage>310</EndPage><MedlinePgn>301-10</MedlinePgn></Pagination><Abstract><AbstractText Label="INTRODUCTION AND OBJECTIVES" NlmCategory="OBJECTIVE">The estimation of Glomerular Filtration Rate (GFR) by Cockroft-Gault or simplified MDRD functions is a powerful tool for the Chronic Kidney Disease (CKD) diagnosis. The aims of the present study are: 1)-To analyze the accuracy between Cockcroft-Gault and simplified MDRD equations in the Hidden Renal Failure (HRF) diagnosis; and 2)-To know the profile and coronary risk of patients diagnosed of HRF for each equation.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">Ten year follow-up of a cross sectional study. A total of 845 patients between 35 and 74 years old (average age 55 years, 56.7% female) without evidence of cardiovascular disease and taken care in a urban primary health center. HRF was defined as an estimated GFR &lt;60 ml/min/1.73 m2 in patients with normal values of creatinine (&lt;1.3 mg/dl in women and &lt;1.4 mg/dl in men )</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">8.3% of studied population had HRF by Cockroft-Gault formula and 11.6% using MDRD. The HRF patients diagnosticated with Cockroft-Gault function were older (67.4 vs 64.4 years, p&lt;0.001) and had a higher coronary risk using either the original Framingham equation and REGICOR function. Furthermore, those HRF patients diagnosticated using MDRD function had a higher body mass index (29.6 vs 26.3 kg/m2, p&lt;0.001) and were women in a greater percentage. Kappa index of agreement of these two equations for diagnosis of HRF was 0,55. The HRF patients diagnosticated exclusively by the use of Cockroft-Gault function were mainly men (75%), older (69.1 vs 61.9 years, p&lt;0.001) and they had a high coronary risk in the Framingham equation (32.7%) and REGICOR function (13.1%)</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Cockroft-Gault and MDRD equations present a moderate agreement in HRF diagnosis (stage 3 of CKD) in patients between 35 and 74 years old. If we only use the MDRD function, a group of HRF patients would be excluded. This population was mainly male (75%), older (69 years old), with a high coronary risk estimated by original Framingham and REGICOR equations, and confirmed in the ten years follow-up of these patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Buitrago</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Centro de salud universitario La Paz, Unidad Docente Medicina Familiar y Comunitaria, Badajoz. fbuitragor@meditex.es</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvo</LastName><ForeName>J I</ForeName><Initials>JI</Initials></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-Jim&#xe9;nez</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Ca&#xf1;&#xf3;n</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Robles</LastName><ForeName>N R</ForeName><Initials>NR</Initials></Author><Author ValidYN="Y"><LastName>Angulo</LastName><ForeName>E</ForeName><Initials>E</Initials></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><VernacularTitle>Comparaci&#xf3;n y concordancia de las ecuaciones de estimaci&#xf3;n de filtrado glomerular de Cockcroft-Gault y MDRD en el diagn&#xf3;stico de enfermedad renal cr&#xf3;nica oculta.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Nefrologia</MedlineTA><NlmUniqueID>8301215</NlmUniqueID><ISSNLinking>0211-6995</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nefrologia. 2008;28(5):561.</RefSource><PMID Version="1">18816218</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003327" MajorTopicYN="N">Coronary Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="Y">Glomerular Filtration Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007676" MajorTopicYN="N">Kidney Failure, Chronic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008433" MajorTopicYN="N">Mathematics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>7</Month><Day>2</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>10</Month><Day>23</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>7</Month><Day>2</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18590497</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">2087593</PMID><DateCompleted><Year>1991</Year><Month>05</Month><Day>20</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0370-4106</ISSN><JournalIssue CitedMedium="Print"><Volume>61</Volume><Issue>4</Issue><PubDate><Year>1990</Year><Season>Jul-Aug</Season></PubDate></JournalIssue><Title>Revista chilena de pediatria</Title><ISOAbbreviation>Rev Chil Pediatr</ISOAbbreviation></Journal><ArticleTitle>[Idiopathic hypercalciuria. Differential diagnosis].</ArticleTitle><Pagination><StartPage>202</StartPage><EndPage>205</EndPage><MedlinePgn>202-5</MedlinePgn></Pagination><Abstract><AbstractText>In 50 children with hematuria or urolithiasis and idiopathic hypercalciuria, and in 15 control children, urinary calcium/creatinine concentration rates were measured after fasting and after calcium loading. Patients were classified into two groups depending on the results of an orally administered calcium loading test. Children were considered to have absorptive hypercalciuria (42%) when they had low fasting urinary calcium/creatinine concentration ratio (less than 0.21), and a large increase of this index after calcium administration (greater than 0.28). Patients were labeled as renal hypercalciuria (32%) if they had high fasting urinary calcium/creatinine concentration ratio (greater than 0.21), and variable increases of it after calcium overload. A third group of children (26%), were not classifiable by means of this test. Our data support the contention that this simple ambulatory test is very useful in the diagnostic workup of idiopathic hypercalciuria.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cano</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Unidad de Nefrolog&#xed;a y Hemodi&#xe1;lisis, Hospital Luis Calvo Mackenna.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Delucchi</LastName><ForeName>M A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Wolff</LastName><ForeName>E</ForeName><Initials>E</Initials></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Hipercalciuria idiop&#xe1;tica. Diagn&#xf3;stico diferencial.</VernacularTitle></Article><MedlineJournalInfo><Country>Chile</Country><MedlineTA>Rev Chil Pediatr</MedlineTA><NlmUniqueID>0404261</NlmUniqueID><ISSNLinking>0370-4106</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>SQE6VB453K</RegistryNumber><NameOfSubstance UI="D002125">Calcium Gluconate</NameOfSubstance></Chemical><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance UI="D002118">Calcium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002118" MajorTopicYN="N">Calcium</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="Y">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002125" MajorTopicYN="N">Calcium Gluconate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006417" MajorTopicYN="N">Hematuria</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014545" MajorTopicYN="N">Urinary Calculi</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1990</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1990</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1990</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">2087593</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>